GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; TRIPS Waiver; compulsory licensing and other IP issues in multiple countries.

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Patent & Trademark Office (PTO); Natl Institutes of Health (NIH)

Taxation/Internal Revenue Code TAX

Proposals to change corporate tax rates and related laws

Contacted: Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); White House Office; Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); State, Dept of (DOS); Natl Institutes of Health (NIH)

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

Contacted: Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Office of the Vice President of the United States; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); White House Office; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Health Issues HCR

Advocate on drug pricing proposals, expanding access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Engage on pharmaceutical policy as it relates to payments under the 340B program. Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments for COVID-19 (2019 Novel Coronavirus), including: manufacturing, clinical trials, reimbursement and coverage of Veklury (remdesivir). H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act

Contacted: Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); White House Office; Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Bills named: H.R. 3 (117th)

Veterans VET

Education related to antivirals and oncology products.

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Office of the Vice President of the United States; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); White House Office; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Advocate on drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to Notice of Benefit and Payment Parameters (NBPP), hospital inpatient payments, and Value-Based Purchasing arrangements.

Contacted: Office of the Vice President of the United States; Food & Drug Administration (FDA); SENATE; White House Office; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Budget/Appropriations BUD

Funding for Hepatitis C, HIV, and public health activities via appropriations.

Contacted: Office of Management & Budget (OMB); White House Office; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); SENATE; Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); Office of the Vice President of the United States